The GDAP1 gene helps keep mitochondria, the cell’s energy units, working properly in nerve cells, especially the long nerves that control movement and feeling in the hands and feet. If it does not work well, those nerves may gradually lose function, which can lead to inherited peripheral neuropathy such as Charcot-Marie-Tooth disease. People with pathogenic variants in the GDAP1 gene may develop foot weakness, high arches, balance problems, numbness, or hand weakness, often starting in childhood or early adulthood. Symptoms can vary widely, depending on the specific variant and whether one or both copies of the gene are affected.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Some genes provide the information needed to make proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
GDAP1Gene function
What if the gene works
The GDAP1 gene helps nerve cells organize their mitochondria, the structures that make energy. This supports a steady energy supply and the upkeep of long nerves, especially in the hands and feet.
Risk
What if the gene does not work
Variants in the GDAP1 gene can cause inherited peripheral neuropathy, most often Charcot-Marie-Tooth disease. Effects range from mild, later-onset walking and hand weakness to earlier, more limiting nerve and muscle problems, depending on how much the variant disrupts gene function.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the GDAP1 gene, no GDAP1-specific treatment or drug choice is currently established in clinical guidelines. Care is usually supportive and guided by symptoms rather than by the GDAP1 variant itself.
Conditions associated with GDAP1
Gene function
What if the gene works
GDAP1 helps your cells manage mitochondria, the parts of cells that make energy. This matters most in nerve cells, which have long branches and need energy delivered over distance. When the GDAP1 gene works properly, mitochondria stay organized and available where the cell needs them.
GDAP1 helps keep mitochondria at the right size and shape. Its protein supports the normal balance between mitochondria joining together and separating.
In nerve cells, mitochondria need to be spread out so distant parts of the cell have power. Much of the GDAP1 gene's normal work in nerve cells centers on helping these energy makers reach the right spots.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including variations in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GDAP1 gene can change the protein's shape, stability, or placement on the mitochondria, the cell's energy-making structures, which disrupts mitochondrial splitting and movement in long nerve cells. This is part of how GDAP1 gene variants affect nerve cell function. Milder variants may leave some activity in place, while more disruptive variants can greatly reduce or abolish it. In GDAP1-related neuropathy, those larger functional losses often link to earlier onset and more marked weakness and sensory changes.
How variants are linked to conditions
Pathogenic variants in the GDAP1 gene are a well-established cause of inherited peripheral nerve conditions, especially GDAP1-related Charcot-Marie-Tooth disease. These conditions can lead to slowly progressive foot and hand weakness, muscle wasting, balance problems, and reduced feeling, often starting in childhood but sometimes later. Some GDAP1-related forms begin early and affect walking more strongly, while others are milder and appear later in life.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GDAP1, risk is mainly shaped by the specific gene change and whether one or both copies of the gene are affected, often within a family pattern. Severity and age when symptoms begin can vary, but there is not enough evidence to say that lifestyle changes lower the chance of developing a GDAP1-related nerve condition.
Inheritance of GDAP1 variants
For GDAP1-related neuropathy, the inheritance pattern depends on the specific variant and condition. Some GDAP1 gene variants are inherited in an autosomal recessive way, which means a child usually needs one altered copy from each parent; when both parents are carriers, each pregnancy has a 25% chance of the child inheriting both altered copies. Other GDAP1 gene variants follow an autosomal dominant pattern, which means one altered copy can be enough to cause the condition and an affected parent has a 50% chance of passing it on to each child. In practical terms, how variants of the GDAP1 gene are inherited can differ within the same family of nerve conditions.
What does my GDAP1 result mean for my family?
A GDAP1 result can matter for close relatives, but the family impact depends on the exact change because GDAP1 is linked to both dominant and recessive forms of an inherited nerve condition called Charcot-Marie-Tooth disease. In some families, a parent, child, brother, or sister may also carry the same change and could have symptoms or develop them later; in others, relatives may be healthy carriers. Family testing may be considered based on the specific GDAP1 result.
Genetic information
Genetic testing
How you find out about variants
GDAP1 genetic testing looks for changes in the GDAP1 gene using a blood sample, saliva, or sometimes a cheek swab. A lab reads the DNA sequence to see whether a variant is present. Results can help explain symptoms such as inherited nerve problems and may show whether the variant runs in a family.
When should I consider getting a genetic test?
Consider testing for the GDAP1 gene if you or your child has signs of an inherited nerve condition such as Charcot-Marie-Tooth disease, including slowly worsening foot weakness, frequent tripping, high arches, numb feet, or hand weakness. Testing can also be helpful when these problems run in the family.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the type of variant involved. Many factors, including age, lifestyle, environment, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to a medication. By studying links between genes and medicines, it helps explain why the same treatment may not work in the same way for every person. With many drugs, genes can influence how strongly a medicine works or how the body handles it. This information can support treatment choices that are both better informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the GDAP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines. If you have side effects, poor symptom control, or questions about how any treatment fits with your health history, talk with your doctor or pharmacist.
History
The GDAP1 gene entered medical genetics in the early 2000s, when researchers linked variants in it to inherited peripheral nerve conditions within the Charcot-Marie-Tooth spectrum. This was an important step because families with early weakness, foot deformities, and walking difficulties had often shared a clear inherited pattern before the cause was known. Early reports showed that GDAP1 variants could be associated with both recessive and dominant forms of disease, which helped explain why symptoms and family histories could look quite different from one household to another. From these first observations, research expanded steadily. As more families were studied, clinicians gained a clearer picture of GDAP1-related neuropathy and how it fits within the broader history of inherited nerve conditions.